Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 13, 2015 1:59 PM ET


Company Overview of Tinea Pharmaceuticals, Inc.

Executive Profile

G. Kirk Raab

Chairman of the Board, Tinea Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 8 different industries.

See Board Relationships


Mr. G. Kirk Raab served as the President and Chief Operating Officer at Genentech Inc. from February 1985 to 1990, and served as Genentech's President and Chief Executive Officer from January 1990 to July 1995. Mr. Raab served as an Interim Chief Executive Officer of LXR Biotechnology from April to August 1998. Mr. Raab served as an Acting Chief Executive Officer of BiPar Sciences Inc. from September 2007 to March 3, 2008. Prior to joining Genentech Inc., in 1985, Mr. ...

Corporate Headquarters

435 Tasso Street
Palo Alto, California 94301-1555

United States

Phone: 650-209-3700
Fax: --

Board Members Memberships

Chairman of the Board
Chairman of the Board and Chairman of Compensation Committee


BA 1959
Colgate University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tinea Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at